Collegium Pharmaceutical, Inc. COLL Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s investing cash flow?
- Collegium Pharmaceutical, Inc. (COLL) reported investing cash flow of $1.63M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s investing cash flow changed year-over-year?
- Collegium Pharmaceutical, Inc.'s investing cash flow increased by 116.8% year-over-year, from -$9.68M to $1.63M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s investing cash flow?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s investing cash flow has grown at a 139.1% compound annual growth rate (CAGR), from -$1.94M to -$63.53M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.